S&P 500

5.460,48

-0,41%

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Início
Investir
Ações
EUA
USOTC
IR BioSciences Holdings Inc New (CE) (IRBS)
IR BioSciences Holdings Inc New (CE) (IRBS) Notícias

IRBS

IR BioSciences (CE) (IRBS)

IR BioSciences Holdings Inc New (CE)

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:USOTC:IRBS

1 2 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
24/05/2011	18:28	Edgar (US Regulatory)	Annual Report (10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
16/05/2011	16:11	Edgar (US Regulatory)	Notification that Quarterly Report will be submitted late (NT 10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
31/03/2011	13:54	Edgar (US Regulatory)	Notification that Annual Report will be submitted late (NT 10-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/03/2011	19:29	Edgar (US Regulatory)	Current report filing (8-K)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
22/11/2010	19:12	Edgar (US Regulatory)	Quarterly Report (10-Q)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
28/10/2010	11:00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Positive Results in Cancer Vaccine Studies in Radboud University Collaboration	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
08/09/2010	08:00	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Reports Scancell Collaboration Yielding Positive Results in Cancer Vaccine Studies of Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
31/08/2010	15:21	GlobeNewswire Inc.	ImmuneRegen BioSciences(R) Invited to Submit Full Proposal to BARDA for Homspera(R) as a Potential Medical Countermeasure for In	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
25/08/2010	10:00	GlobeNewswire Inc.	University of Rochester Medical Center Receives $15 Million in Government Funding to Research ImmuneRegen's Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
05/08/2010	09:27	Marketwired	/ CORRECTION - ImmuneRegen BioSciences	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
04/08/2010	08:00	Marketwired	ImmuneRegen BioSciences Completes Successful Reduction of Debt	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
30/04/2010	18:17	Edgar (US Regulatory)	Amended Annual Report (10-K/A)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
27/04/2010	09:00	Marketwired	ImmuneRegen BioSciences(R) Announces Collaboration With the Department of Tumor Immunology of the Radboud University Nijmegen Me	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
21/04/2010	09:00	Marketwired	ImmuneRegen BioSciences(R) Initiates Strategic Collaboration With MPI Research to Accelerate Clinical Development of Lead Indica	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
19/04/2010	14:00	Marketwired	ImmuneRegen BioSciences(R) Retains Redwood Consultants, LLC to Assist in Shareholder Relations and Strategic Planning	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
04/03/2010	10:00	Marketwired	ImmuneRegen BioSciences Submits Homspera(R) for FDA Orphan Drug Product Designation for the Treatment of Idiopathic Pulmonary Fi	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/02/2010	11:00	Marketwired	Fred Hutchinson Cancer Research Center Initiates Studies on ImmuneRegen BioSciences' Cancer Therapy Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
27/01/2010	11:00	Marketwired	National Cancer Institute Initiates Studies on ImmuneRegen BioSciences' Vaccine Adjuvant Candidate	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
26/01/2010	17:54	Marketwired	IR Biosciences' ImmuneRegen (OTCBB: IRBS) Getting Attention for Its Adult Stem Cell Active Compound	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
05/01/2010	11:00	Marketwired	ImmuneRegen BioSciences(R) Reports Additional Positive Results From Study of Homspera(R) in Treating Highly Pathogenic Influenza	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
24/12/2009	11:00	Marketwired	ImmuneRegen BioSciences(R) Summarizes Previous 9 Months of Advances as Homspera(R) Development Continues	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
21/12/2009	11:00	Marketwired	ImmuneRegen BioSciences'(R) Reports Efficacy of a New Adjuvant of a Preventive Cancer Vaccine	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
14/12/2009	11:00	Marketwired	ImmuneRegen BioSciences'(R) Drug Candidate Homspera Confirms Efficacy as Cancer Vaccine Adjuvant	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
10/11/2009	11:00	Marketwired	ImmuneRegen BioSciences(R) Reports Positive Results of Homspera(R) in Treating Highly Pathogenic Influenza	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
22/10/2009	10:00	Marketwired	ImmuneRegen BioSciences(R) to Further Homspera(R) Research in Study Funded by U.S. Government	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
12/10/2009	09:00	Marketwired	ImmuneRegen BioSciences(R) Initiates Homspera(R) Studies Against Global Influenza Threat	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
23/09/2009	09:00	Marketwired	ImmuneRegen BioSciences(R) Announces Strategic Partnership With Azopharma Product Development Group, Inc.	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
22/09/2009	09:00	Marketwired	ImmuneRegen BioSciences(R) Announces Partnership With Bachem, Inc., for Manufacturing of Homspera(R)	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
09/09/2009	09:00	Marketwired	ImmuneRegen BioSciences(R) Partners With University of Rochester in BARDA Funding Bid	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)
26/08/2009	09:00	Marketwired	ImmuneRegen BioSciences(R) Announces Collaboration With Archimedes Development Limited	USOTC:IRBS	IR BioSciences Holdings Inc New (CE)